Ida Holme, MD

Director in Clinical Risk Management and Oversight
Novo Nordisk
 

Ida Holme, MD, is Director of the RBQM Clinical Office at Novo Nordisk, where she leads the implementation of Integrated Quality  Risk Management across clinical development. A physician by training, Ida has more than 20 years of pharmaceutical industry experience across clinical development, patient safety, and quality management, including roles at Sanofi, LEO Pharma, and Novo Nordisk. She is passionate about holistic perspective to clinical research, quality by design, and risk-based decision-making early to design studies that are both scientifically robust and meaningful for patients.